The global opioids market size was US$ 4.7 billion in 2021. The global opioids market size is forecast to reach US$ 6.3 billion by 2030, growing at a compound annual growth rate (CAGR) of 3.5% during the forecast period from 2022 to 2030.
Opioids are medications that help to treat severe or chronic pain, such as chronic headaches and backaches. In addition, patients recovering from surgery or experiencing severe pain related to cancer. In addition, adults and children that injured while playing sports or had severely injured in falls, auto accidents, or other incidents. Opioids are also referred to as narcotics. Doctors prescribe various opioids of varying strengths that can administer in many ways depending on the patient, the situation, and the type and level of pain. Although some opioids can use to treat cough and diarrhea, several prescription opioids are used to treat moderate to severe pain.
Factors Influencing Market Growth
Impact Analysis of COVID-19
The COVID-19 pandemic had a negative impact on the global market. Several governments worldwide imposed a lockdown in order to curb the spread of the deadly virus. This led to the closure of various non-essential clinics and hospitals. In addition, various hospitals and clinics had to focus on treating COVID-19 patients. As a result, several other treatments were put on halt.
Regional Analysis
North America garnered the major market share in 2021 and is forecast to maintain its position during the forecast period. As a result of the rising demand for opioid drugs, growing healthcare expenditures, and an increasing number of surgeries.
The Asia Pacific region is forecast to have lucrative growth during the forecast period. As a result of the increasing incidence of the population suffering from many diseases like migraine, arthritis, and cancer pain disease and the rising aging population. In addition, a surge in healthcare expenditure fuels the market growth in the region.
Leading Companies
The leading prominent companies profiled in the global opioid market are:
Scope of the Report
The global opioid market segmentation focuses on Application, Product Type, and Region.
Segmentation based on Application
Segmentation based on Product Type
Segmentation based on Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL OPIOIDS MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
4 GLOBAL OPIOIDS MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE MODEL
4.4 VALUE CHAIN ANALYSIS
5 GLOBAL OPIOIDS MARKET, BY APPLICATION
5.1 OVERVIEW
5.2 PAIN MANAGEMENT
5.3 COUGH TREATMENT
5.4 DIARRHEA TREATMENT
6 GLOBAL OPIOIDS MARKET, BY PRODUCT TYPE
6.1 OVERVIEW
6.2 METHADONE
6.3 CODEINE
6.4 FENTANYL
6.5 OXYCODONE
6.6 MORPHINE
6.7 HYDROCODONE
6.8 OTHERS
7 GLOBAL OPIOIDS MARKET, BY GEOGRAPHY
7.1 OVERVIEW
7.2 NORTH AMERICA
7.2.1 NORTH AMERICA MARKET SNAPSHOT
7.2.2 U.S.
7.2.3 CANADA
7.2.4 MEXICO
7.3 EUROPE
7.3.1 EUROPE MARKET SNAPSHOT
7.3.2 WESTERN EUROPE
7.3.2.1 THE UK
7.3.2.2 GERMANY
7.3.2.3 FRANCE
7.3.2.4 ITALY
7.3.2.5 SPAIN
7.3.2.6 REST OF WESTERN EUROPE
7.3.3 EASTERN EUROPE
7.3.3. 1 POLAND
7.3.3.2 RUSSIA
7.3.3.3 REST OF EASTERN EUROPE
7.4 ASIA PACIFIC
7.4.1 ASIA PACIFIC MARKET SNAPSHOT
7.4.2 CHINA
7.4.3 JAPAN
7.4.4 INDIA
7.4.5 AUSTRALIA & NEW ZEALAND
7.4.6 ASEAN
7.4.7 REST OF ASIA PACIFIC
7.5 MIDDLE EAST & AFRICA
7.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
7.5.2 UAE
7.5.3 SAUDI ARABIA
7.5.4 SOUTH AFRICA
7.5.5 REST OF MEA
7.6 SOUTH AMERICA
7.6.1 SOUTH AMERICA MARKET SNAPSHOT
7.6.2 BRAZIL
7.6.3 ARGENTINA
7.6.4 REST OF SOUTH AMERICA
8 GLOBAL OPIOIDS MARKET COMPETITIVE LANDSCAPE
8.1 OVERVIEW
8.2 COMPANY MARKET RANKING
8.3 KEY DEVELOPMENT STRATEGIES
9 COMPANY PROFILES
9.1 TEVA PHARMACEUTICAL INDUSTRIES LIMITED
9.1.1 OVERVIEW
9.1.2 FINANCIAL PERFORMANCE
9.1.3 PRODUCT OUTLOOK
9.1.4 KEY DEVELOPMENTS
9.2 PURDUE PHARMA LP
9.2.1 OVERVIEW
9.2.2 FINANCIAL PERFORMANCE
9.2.3 PRODUCT OUTLOOK
9.2.4 KEY DEVELOPMENTS
9.3 ASTRAZENECA PLC
9.3.1 OVERVIEW
9.3.2 FINANCIAL PERFORMANCE
9.3.3 PRODUCT OUTLOOK
9.3.4 KEY DEVELOPMENTS
9.4 C.H. BOEHRINGER SOHN AG AND KO. KG
9.4.1 OVERVIEW
9.4.2 FINANCIAL PERFORMANCE
9.4.3 PRODUCT OUTLOOK
9.4.4 KEY DEVELOPMENTS
9.5 JOHNSON & JOHNSON, INC.
9.5.1 OVERVIEW
9.5.2 FINANCIAL PERFORMANCE
9.5.3 PRODUCT OUTLOOK
9.5.4 KEY DEVELOPMENTS
9.6 SANOFI S.A.
9.6.1 OVERVIEW
9.6.2 FINANCIAL PERFORMANCE
9.6.3 PRODUCT OUTLOOK
9.6.4 KEY DEVELOPMENTS
9.7 MALLINCKRODT PHARMACEUTICALS
9.7.1 OVERVIEW
9.7.2 FINANCIAL PERFORMANCE
9.7.3 PRODUCT OUTLOOK
9.7.4 KEY DEVELOPMENTS
9.8 ENDO PHARMACEUTICALS INCORPORATED
9.8.1 OVERVIEW
9.8.2 FINANCIAL PERFORMANCE
9.8.3 PRODUCT OUTLOOK
9.8.4 KEY DEVELOPMENTS
9.9 PFIZER, INCORPORATED
9.9.1 OVERVIEW
9.9.2 FINANCIAL PERFORMANCE
9.9.3 PRODUCT OUTLOOK
9.9.4 KEY DEVELOPMENTS
9.10 SUN PHARMACEUTICALS
9.10.1 OVERVIEW
9.10.2 FINANCIAL PERFORMANCE
9.10.3 PRODUCT OUTLOOK
9.10.4 KEY DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved